Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F B Oleson

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Chemico-Biological Interactions|November 13, 2004
An evaluation of the P450 inhibition and induction potential of daptomycin in primary human hepatocytesF B Oleson, C L Berman, A P Li
Nucleic Acids Research|November 10, 1979
Distribution of DNA damage in chromatin and its relation to repair in human cells treated with 7-bromomethylbenz(a) anthraceneF B Oleson, B L Mitchell, A Dipple, et al.
Toxicologic Pathology|January 1, 1988
Gastric enterochromaffin-like cell hyperplasia and neoplasia in the rat: an indirect effect of the histamine H2-receptor antagonist, BL-6341R S Hirth, L D Evans, R A Buroker, et al.
International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine|January 1, 1977
Survival of synchronized V79 cells treated with X-rays and cordycepinJ B Robertson, F B Oleson, J R Williams, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 25, 2010
Characterization of rabbit primary proximal tubule kidney cell cultures grown on Millicell-HA membrane filtersM J Palmoski, B A Masters, O P Flint, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|April 1, 1993
Acute cardiotoxicity of nucleoside analogs FddA and FddI in ratsC R Comereski, W A Kelly, T J Davidson, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
Once-daily dosing in dogs optimizes daptomycin safetyF B Oleson, C L Berman, J B Kirkpatrick, et al.
Expert Opinion on Investigational Drugs|July 5, 2005
Daptomycin: a novel agent for Gram-positive infectionsF P Tally, M Zeckel, M M Wasilewski, et al.
Therapeutic Immunology|August 1, 1994
The effects of an immunomodulatory LFA3-IgG1 fusion protein on nonhuman primatesP L Chisholm, C A Williams, W E Jones, et al.
Therapeutic Immunology|June 1, 1995
Immunomodulation by LFA3TIP, an LFA-3/IgG1 fusion protein: cell line dependent glycosylation effects on pharmacokinetics and pharmacodynamic markersW Meier, A Gill, M Rogge, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Chemico-Biological Interactions|November 13, 2004
An evaluation of the P450 inhibition and induction potential of daptomycin in primary human hepatocytesF B Oleson, C L Berman, A P Li
Nucleic Acids Research|November 10, 1979
Distribution of DNA damage in chromatin and its relation to repair in human cells treated with 7-bromomethylbenz(a) anthraceneF B Oleson, B L Mitchell, A Dipple, et al.
Toxicologic Pathology|January 1, 1988
Gastric enterochromaffin-like cell hyperplasia and neoplasia in the rat: an indirect effect of the histamine H2-receptor antagonist, BL-6341R S Hirth, L D Evans, R A Buroker, et al.
International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine|January 1, 1977
Survival of synchronized V79 cells treated with X-rays and cordycepinJ B Robertson, F B Oleson, J R Williams, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 25, 2010
Characterization of rabbit primary proximal tubule kidney cell cultures grown on Millicell-HA membrane filtersM J Palmoski, B A Masters, O P Flint, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|April 1, 1993
Acute cardiotoxicity of nucleoside analogs FddA and FddI in ratsC R Comereski, W A Kelly, T J Davidson, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
Once-daily dosing in dogs optimizes daptomycin safetyF B Oleson, C L Berman, J B Kirkpatrick, et al.
Expert Opinion on Investigational Drugs|July 5, 2005
Daptomycin: a novel agent for Gram-positive infectionsF P Tally, M Zeckel, M M Wasilewski, et al.
Therapeutic Immunology|August 1, 1994
The effects of an immunomodulatory LFA3-IgG1 fusion protein on nonhuman primatesP L Chisholm, C A Williams, W E Jones, et al.
Therapeutic Immunology|June 1, 1995
Immunomodulation by LFA3TIP, an LFA-3/IgG1 fusion protein: cell line dependent glycosylation effects on pharmacokinetics and pharmacodynamic markersW Meier, A Gill, M Rogge, et al.
Pageof 2